Nivolumab plus relatlimab with platinum-doublet chemotherapy versus nivolumab with platinum-doublet chemotherapy in stage IV or recurrent non-small cell lung cancer: clinical, translational, and patient-reported outcomes results from the phase II RELATIVITY-104 study

Annals of Oncology · Elsevier

Abstract

Publication date: Available online 23 October 2026 Source: Annals of Oncology Author(s): N. Girard, M. Burotto, L.G. Paz-Ares, M. Schenker, A. Lingua, F. Orlandi, J. Naidoo, E.K. Beardsley, V. Velcheti, G.L. Martinengo, E. Felip, M. Reck, A. Qureshi, P. Kasbekar, S. Samanta, J. Neely, Charlie Garnett-Benson, L. McDonald, J.X. Yu, M. Cobo-Dols

Read at publisher →

Similar articles